Pentraxin-3 showed a statistically significant difference between survivors and non-survivors; this may be due to the general inflammatory state of people with diabetes [28] and could be associated with infection and consecutive sepsis in some IDFU patients, given that pentraxin-3 is a known marker of sepsis [29]. This evidence concerns the gene PTX3 and diabetes mellitus.